Semnur Pharmaceuticals, Inc.

Over the past 90 days, Semnur Pharmaceuticals (SMNR) has reported zero cyber incidents and zero red-flag 8-K filings related to bankruptcy, delisting, restatement, or officer departures. This absence of acute disclosure events provides a baseline, though low signal in a 90-day window does not eliminate underlying risk; a fuller picture requires 12-month context and structural analysis. The full $49 Report adds dilution risk scoring, complete 8-K filing history, equity and debt financing patterns, and AI-detected risk signals that may not yet surface in headline events. This deeper framework helps distinguish temporary quiet from genuine stability.